Wenbing Yao - Search Results

Year	Number of Results
2004	1
2005	1
2006	1
2007	2
2008	4
2009	6
2010	9
2011	4
2012	10
2013	14
2014	10
2015	5
2016	10
2017	10
2018	13
2019	10
2020	11
2021	11
2022	4
2023	6
2024	7

1

Crosstalk in extrahepatic and hepatic system in NAFLD/NASH.

Duan Y, Yang Y, Zhao S, Bai Y, Yao W, Gao X, Yin J. Duan Y, et al. Among authors: yao w. Liver Int. 2024 Aug;44(8):1856-1871. doi: 10.1111/liv.15967. Epub 2024 May 8. Liver Int. 2024. PMID: 38717072 Review.

2

β-Lactamase inhibitors: an update.

Chen J, Shang X, Hu F, Lao X, Gao X, Zheng H, Yao W. Chen J, et al. Among authors: yao w. Mini Rev Med Chem. 2013 Nov;13(13):1846-61. doi: 10.2174/13895575113139990074. Mini Rev Med Chem. 2013. PMID: 23895190 Review.

3

Light-Controlled Tyrosine Nitration of Proteins.

Long T, Liu L, Tao Y, Zhang W, Quan J, Zheng J, Hegemann JD, Uesugi M, Yao W, Tian H, Wang H. Long T, et al. Among authors: yao w. Angew Chem Int Ed Engl. 2021 Jun 7;60(24):13414-13422. doi: 10.1002/anie.202102287. Epub 2021 May 10. Angew Chem Int Ed Engl. 2021. PMID: 33847040

4

Tailored protein-conjugated DNA nanoplatform for synergistic cancer therapy.

Liu D, Chen Y, Wang Q, Ji Y, Bao L, Yao W, Gao X, Yin J. Liu D, et al. Among authors: yao w. J Control Release. 2022 Jun;346:250-259. doi: 10.1016/j.jconrel.2022.04.022. Epub 2022 Apr 27. J Control Release. 2022. PMID: 35452765

5

A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis.

Wu Z, Dong Z, Luo J, Hu W, Tong Y, Gao X, Yao W, Tian H, Wang X. Wu Z, et al. Among authors: yao w. Genomics. 2024 May;116(3):110831. doi: 10.1016/j.ygeno.2024.110831. Epub 2024 Mar 20. Genomics. 2024. PMID: 38513875 Free article.

6

Characterization of a monoPEG20000-Endostar.

Tong Y, Zhong K, Tian H, Gao X, Xu X, Yin X, Yao W. Tong Y, et al. Among authors: yao w. Int J Biol Macromol. 2010 Apr 1;46(3):331-6. doi: 10.1016/j.ijbiomac.2010.01.017. Epub 2010 Feb 1. Int J Biol Macromol. 2010. PMID: 20122957

7

Real-world safety of Lacosamide: A pharmacovigilance study based on spontaneous reports in the FDA adverse event reporting system.

Liu P, He M, Xu X, He Y, Yao W, Liu B. Liu P, et al. Among authors: yao w. Seizure. 2023 Aug;110:203-211. doi: 10.1016/j.seizure.2023.07.003. Epub 2023 Jul 5. Seizure. 2023. PMID: 37423166 Free article.

8

Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer's disease.

Wang Y, Du Y, Huang H, Cao Y, Pan K, Zhou Y, He J, Yao W, Chen S, Gao X. Wang Y, et al. Among authors: yao w. Pharmacol Res. 2024 Apr;202:107133. doi: 10.1016/j.phrs.2024.107133. Epub 2024 Mar 6. Pharmacol Res. 2024. PMID: 38458367 Free article.

9

A long-acting FGF21 attenuates metabolic dysfunction-associated steatohepatitis-related fibrosis by modulating NR4A1-mediated Ly6C phenotypic switch in macrophages.

Ji Y, Duan Y, Li Y, Lu Q, Liu D, Yang Y, Chang R, Tian J, Yao W, Yin J, Gao X. Ji Y, et al. Among authors: yao w. Br J Pharmacol. 2024 Aug;181(16):2923-2946. doi: 10.1111/bph.16378. Epub 2024 Apr 28. Br J Pharmacol. 2024. PMID: 38679486

10

A peptide rich in glycine-serine-alanine repeats ameliorates Alzheimer-type neurodegeneration.

Yao SY, Wang JF, Xu Z, Meng Y, Xue Y, Yang F, Yao WB, Gao XD, Chen S. Yao SY, et al. Br J Pharmacol. 2023 Jul;180(14):1878-1896. doi: 10.1111/bph.16048. Epub 2023 Feb 28. Br J Pharmacol. 2023. PMID: 36727262 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

129 results

Results by year